Horizon Pharma (HZNP) Surges 9% on Q4 Results

Horizon Pharma plc (HZNP) shares are up $1.78, or 9.7%, to $20.85 in pre-market trading Friday after the company reported its fourth quarter earnings results. The specialty pharmaceutical firm reported earnings of $0.27 per share on revenues of $103.8 million, up a staggering 244.9% from a year ago. Analysts were expecting EPS of $0.21 on […] View the full post at: Horizon Pharma (HZNP) Surges 9% on Q4 Results Related posts: JPMorgan Posts Better-than-Expected Results After-Hours Earnings (April 15) Rethinking California’s Revenue Structure